Neonatal Health

Newborn Screening Ontario (NSO) and the CHEO Research Institute are conducting the INFANT Study to explore how genomic newborn screening could help identify rare genetic conditions earlier in life.

Join the Annual Respiratory Syncytial Virus (RSV) Conference on September 23, 2026, for a virtual program focused on bringing the latest RSV research and evidence into clinical practice.

Hospitals across Ontario are reporting an increase in families declining the recommended intramuscular (IM) Vitamin K injection at birth. While this decision may be perceived as low risk, refusal increases the risk of Vitamin K Deficiency Bleeding (VKDB)—a rare but potentially serious and preventable condition in newborns.